c caspase 3  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Boster Bio c caspase 3
    Partial results of molecular docking. Molecular docking of ( A ) C12 and <t>caspase-3</t> (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).
    C Caspase 3, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c caspase 3/product/Boster Bio
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c caspase 3 - by Bioz Stars, 2022-09
    90/100 stars

    Images

    1) Product Images from "Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway"

    Article Title: Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway

    Journal: Drug Design, Development and Therapy

    doi: 10.2147/DDDT.S280217

    Partial results of molecular docking. Molecular docking of ( A ) C12 and caspase-3 (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).
    Figure Legend Snippet: Partial results of molecular docking. Molecular docking of ( A ) C12 and caspase-3 (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).

    Techniques Used:

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90
    Boster Bio c caspase 3
    Partial results of molecular docking. Molecular docking of ( A ) C12 and <t>caspase-3</t> (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).
    C Caspase 3, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c caspase 3/product/Boster Bio
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c caspase 3 - by Bioz Stars, 2022-09
    90/100 stars
      Buy from Supplier

    91
    Boster Bio rabbit anti rat caspase 3 monoclonal antibody
    <t>Caspase-3</t> expression in retinal ganglial cells (RGCs) in rats (immunofluorescence staining, × 200). Following acute ocular hypertension, Caspase-3 positive expression is detected in the rat retina, mainly in the cytoplasm, and gradually decreased by 2 days. Green fluorescence spots represents caspase-3-positive cells. Fluorescein served as the fluorescent dye.
    Rabbit Anti Rat Caspase 3 Monoclonal Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti rat caspase 3 monoclonal antibody/product/Boster Bio
    Average 91 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti rat caspase 3 monoclonal antibody - by Bioz Stars, 2022-09
    91/100 stars
      Buy from Supplier

    80
    Boster Bio c caspase 9
    Partial results of molecular docking. Molecular docking of ( A ) C12 and caspase-3 (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and <t>caspase-9</t> (2AR9).
    C Caspase 9, supplied by Boster Bio, used in various techniques. Bioz Stars score: 80/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c caspase 9/product/Boster Bio
    Average 80 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c caspase 9 - by Bioz Stars, 2022-09
    80/100 stars
      Buy from Supplier

    90
    Boster Bio mouse xaf1 antibody middle region oaab14914
    SARM1 deficiency enhanced apoptosis in prion-infected SARM1 −/− brains (A-B) Caspase 3 (A) and caspase 9 (B) activity assay of RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mouse brains at 112 dpi. n= 8 for SARM1 −/− and n=4 for SARM1 +/− and SARM1 +/+ (WT) mice. Relative caspase 3 and caspase 9 activity was represented as percentage of average values in SARM1 +/+ mice. (C) Left: TUNEL staining of brain tissues from RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice at 112 dpi. Right: Quantification of TUNEL positive cells. n=7 for SARM1 −/− and n=3 for SARM1 +/− and SARM1 +/+ (WT) mice. Scale bars: 10μm. (D) Left: Western blot for synapsin I on brains collected from terminally sick RML6-infected C57BL/6 mice and age-matched NBH-inoculated C57BL/6 mice. Right: Densitometric quantification of the synapsin I Western blot showed significant reduction of synapsin I in RML6-infected brains. n=5 for NBH-treated and RML6-treated mice. Relative signal intensity was represented as percentage of average values in NBH-treated mice. (E) Left: Western blot for synapsin I in uninfected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice. Right: Densitometric quantification of the synapsin I Western blots showed unchanged synapsin I level in uninfected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice. n=3 for SARM1 +/− and SARM1 +/+ (WT) mice, n=5 for SARM1 −/− mice. Relative signal intensity was represented as percentage of average values in SARM1 +/+ mice. (F) Left: Western blot for synapsin I in RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mouse brains at 112 dpi. Right: Densitometric quantification of the synapsin I Western blot. n=3 for each genotype. The relative signal intensity was represented as percentage of average values in SARM1 +/+ mice. (G) Caspase 3 activity assay of wild type (WT) CAD5 and <t>XAF1</t> KO CAD5 cell lysates after SARM1 siRNAs and TNFα treatments. (H) Caspase 9 activity assay of WT CAD5 and XAF1 KO CAD5 cell lysates after SARM1 siRNAs and TNFα treatments. n=3. Relative caspase 3 and caspase 9 activity was represented as percentage of average values in PBS groups. (I) RealTime-Glo assay of live WT CAD5 and XAF1 KO CAD5 cells after SARM1 siRNAs and TNFα treatments. n=6. Relative cell numbers were represented as percentage of average values in PBS groups. Relative caspase 3 and caspase 9 activity measurement represents two independent experiments. (J) Sequencing results of Xaf1 gene in XAF1 KO CAD5 cells showed that the coding sequence of all sequenced clones was frameshifted. Western blot results represent at least three independent experiments.
    Mouse Xaf1 Antibody Middle Region Oaab14914, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse xaf1 antibody middle region oaab14914/product/Boster Bio
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse xaf1 antibody middle region oaab14914 - by Bioz Stars, 2022-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Partial results of molecular docking. Molecular docking of ( A ) C12 and caspase-3 (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).

    Journal: Drug Design, Development and Therapy

    Article Title: Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway

    doi: 10.2147/DDDT.S280217

    Figure Lengend Snippet: Partial results of molecular docking. Molecular docking of ( A ) C12 and caspase-3 (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).

    Article Snippet: AntibodiesPrimary antibodies against B-cell lymphoma (Bcl)-2, Bax, phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), phosphorylated (p)-PI3K, p-Akt, c-caspase 3, c-caspase 9, and β-actin were acquired from Boster Biological (Wuhan, China).

    Techniques:

    Caspase-3 expression in retinal ganglial cells (RGCs) in rats (immunofluorescence staining, × 200). Following acute ocular hypertension, Caspase-3 positive expression is detected in the rat retina, mainly in the cytoplasm, and gradually decreased by 2 days. Green fluorescence spots represents caspase-3-positive cells. Fluorescein served as the fluorescent dye.

    Journal: Neural Regeneration Research

    Article Title: Alpha B-crystallin improved survival of retinal ganglion cells in a rat model of acute ocular hypertension ☆

    doi: 10.3969/j.issn.1673-5374.2012.19.008

    Figure Lengend Snippet: Caspase-3 expression in retinal ganglial cells (RGCs) in rats (immunofluorescence staining, × 200). Following acute ocular hypertension, Caspase-3 positive expression is detected in the rat retina, mainly in the cytoplasm, and gradually decreased by 2 days. Green fluorescence spots represents caspase-3-positive cells. Fluorescein served as the fluorescent dye.

    Article Snippet: Briefly, the retina was blocked in 3% bovine serum albumin at 4°C for 1 hour, incubated with rabbit anti-rat caspase-3 monoclonal antibody (1:500; Wuhan Boster Biotechnology, Wuhan, China) at 4°C for 12 hours, followed by fluorescein-labeled goat anti-rabbit IgG (1:200; Wuhan Boster Biotechnology) at 4°C for 2 hours.

    Techniques: Expressing, Immunofluorescence, Staining, Fluorescence

    αB-crystallin decreased caspase-3 expression in a rat model of acute ocular hypertension

    Journal: Neural Regeneration Research

    Article Title: Alpha B-crystallin improved survival of retinal ganglion cells in a rat model of acute ocular hypertension ☆

    doi: 10.3969/j.issn.1673-5374.2012.19.008

    Figure Lengend Snippet: αB-crystallin decreased caspase-3 expression in a rat model of acute ocular hypertension

    Article Snippet: Briefly, the retina was blocked in 3% bovine serum albumin at 4°C for 1 hour, incubated with rabbit anti-rat caspase-3 monoclonal antibody (1:500; Wuhan Boster Biotechnology, Wuhan, China) at 4°C for 12 hours, followed by fluorescein-labeled goat anti-rabbit IgG (1:200; Wuhan Boster Biotechnology) at 4°C for 2 hours.

    Techniques: Expressing

    Partial results of molecular docking. Molecular docking of ( A ) C12 and caspase-3 (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).

    Journal: Drug Design, Development and Therapy

    Article Title: Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway

    doi: 10.2147/DDDT.S280217

    Figure Lengend Snippet: Partial results of molecular docking. Molecular docking of ( A ) C12 and caspase-3 (3H0E), ( B ) C22 and Bcl-2 (6RNU), ( C ) C102 and Bax (2G5B), ( D ) C102 and caspase-9 (2AR9).

    Article Snippet: AntibodiesPrimary antibodies against B-cell lymphoma (Bcl)-2, Bax, phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), phosphorylated (p)-PI3K, p-Akt, c-caspase 3, c-caspase 9, and β-actin were acquired from Boster Biological (Wuhan, China).

    Techniques:

    SARM1 deficiency enhanced apoptosis in prion-infected SARM1 −/− brains (A-B) Caspase 3 (A) and caspase 9 (B) activity assay of RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mouse brains at 112 dpi. n= 8 for SARM1 −/− and n=4 for SARM1 +/− and SARM1 +/+ (WT) mice. Relative caspase 3 and caspase 9 activity was represented as percentage of average values in SARM1 +/+ mice. (C) Left: TUNEL staining of brain tissues from RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice at 112 dpi. Right: Quantification of TUNEL positive cells. n=7 for SARM1 −/− and n=3 for SARM1 +/− and SARM1 +/+ (WT) mice. Scale bars: 10μm. (D) Left: Western blot for synapsin I on brains collected from terminally sick RML6-infected C57BL/6 mice and age-matched NBH-inoculated C57BL/6 mice. Right: Densitometric quantification of the synapsin I Western blot showed significant reduction of synapsin I in RML6-infected brains. n=5 for NBH-treated and RML6-treated mice. Relative signal intensity was represented as percentage of average values in NBH-treated mice. (E) Left: Western blot for synapsin I in uninfected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice. Right: Densitometric quantification of the synapsin I Western blots showed unchanged synapsin I level in uninfected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice. n=3 for SARM1 +/− and SARM1 +/+ (WT) mice, n=5 for SARM1 −/− mice. Relative signal intensity was represented as percentage of average values in SARM1 +/+ mice. (F) Left: Western blot for synapsin I in RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mouse brains at 112 dpi. Right: Densitometric quantification of the synapsin I Western blot. n=3 for each genotype. The relative signal intensity was represented as percentage of average values in SARM1 +/+ mice. (G) Caspase 3 activity assay of wild type (WT) CAD5 and XAF1 KO CAD5 cell lysates after SARM1 siRNAs and TNFα treatments. (H) Caspase 9 activity assay of WT CAD5 and XAF1 KO CAD5 cell lysates after SARM1 siRNAs and TNFα treatments. n=3. Relative caspase 3 and caspase 9 activity was represented as percentage of average values in PBS groups. (I) RealTime-Glo assay of live WT CAD5 and XAF1 KO CAD5 cells after SARM1 siRNAs and TNFα treatments. n=6. Relative cell numbers were represented as percentage of average values in PBS groups. Relative caspase 3 and caspase 9 activity measurement represents two independent experiments. (J) Sequencing results of Xaf1 gene in XAF1 KO CAD5 cells showed that the coding sequence of all sequenced clones was frameshifted. Western blot results represent at least three independent experiments.

    Journal: bioRxiv

    Article Title: SARM1 deficiency, which prevents Wallerian degeneration, upregulates XAF1 and accelerates prion disease

    doi: 10.1101/485052

    Figure Lengend Snippet: SARM1 deficiency enhanced apoptosis in prion-infected SARM1 −/− brains (A-B) Caspase 3 (A) and caspase 9 (B) activity assay of RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mouse brains at 112 dpi. n= 8 for SARM1 −/− and n=4 for SARM1 +/− and SARM1 +/+ (WT) mice. Relative caspase 3 and caspase 9 activity was represented as percentage of average values in SARM1 +/+ mice. (C) Left: TUNEL staining of brain tissues from RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice at 112 dpi. Right: Quantification of TUNEL positive cells. n=7 for SARM1 −/− and n=3 for SARM1 +/− and SARM1 +/+ (WT) mice. Scale bars: 10μm. (D) Left: Western blot for synapsin I on brains collected from terminally sick RML6-infected C57BL/6 mice and age-matched NBH-inoculated C57BL/6 mice. Right: Densitometric quantification of the synapsin I Western blot showed significant reduction of synapsin I in RML6-infected brains. n=5 for NBH-treated and RML6-treated mice. Relative signal intensity was represented as percentage of average values in NBH-treated mice. (E) Left: Western blot for synapsin I in uninfected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice. Right: Densitometric quantification of the synapsin I Western blots showed unchanged synapsin I level in uninfected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mice. n=3 for SARM1 +/− and SARM1 +/+ (WT) mice, n=5 for SARM1 −/− mice. Relative signal intensity was represented as percentage of average values in SARM1 +/+ mice. (F) Left: Western blot for synapsin I in RML6-infected SARM1 −/− , SARM1 +/− and SARM1 +/+ (WT) mouse brains at 112 dpi. Right: Densitometric quantification of the synapsin I Western blot. n=3 for each genotype. The relative signal intensity was represented as percentage of average values in SARM1 +/+ mice. (G) Caspase 3 activity assay of wild type (WT) CAD5 and XAF1 KO CAD5 cell lysates after SARM1 siRNAs and TNFα treatments. (H) Caspase 9 activity assay of WT CAD5 and XAF1 KO CAD5 cell lysates after SARM1 siRNAs and TNFα treatments. n=3. Relative caspase 3 and caspase 9 activity was represented as percentage of average values in PBS groups. (I) RealTime-Glo assay of live WT CAD5 and XAF1 KO CAD5 cells after SARM1 siRNAs and TNFα treatments. n=6. Relative cell numbers were represented as percentage of average values in PBS groups. Relative caspase 3 and caspase 9 activity measurement represents two independent experiments. (J) Sequencing results of Xaf1 gene in XAF1 KO CAD5 cells showed that the coding sequence of all sequenced clones was frameshifted. Western blot results represent at least three independent experiments.

    Article Snippet: Supplementary figure 2 (A-G) Western blots for XAF1 in CAD5 cell lysates using various anti-XAF1 antibodies: (A) Abcam (ab17204); (B) Abcam (ab81353); (C) Aviva System Biology (OAAB14914); (D) Boster (A03432); (E) GeneTex (GTX51339); (F) Invitrogene (PA1-41099); (G) Novus Biologicals (NB100-56355).

    Techniques: Infection, Activity Assay, Mouse Assay, TUNEL Assay, Staining, Western Blot, Caspase-3 Activity Assay, Glo Assay, Sequencing, Clone Assay

    SARM1 deficiency and prion infection upregulated XAF1 expression in mouse brains (A) Volcano plots of RNAseq data for uninfected (A) and RML6-infected (112dpi) (B) SARM1 −/− and WT mouse brains. Significants (red dots) are genes that show log2 ratio > 1 or

    Journal: bioRxiv

    Article Title: SARM1 deficiency, which prevents Wallerian degeneration, upregulates XAF1 and accelerates prion disease

    doi: 10.1101/485052

    Figure Lengend Snippet: SARM1 deficiency and prion infection upregulated XAF1 expression in mouse brains (A) Volcano plots of RNAseq data for uninfected (A) and RML6-infected (112dpi) (B) SARM1 −/− and WT mouse brains. Significants (red dots) are genes that show log2 ratio > 1 or

    Article Snippet: Supplementary figure 2 (A-G) Western blots for XAF1 in CAD5 cell lysates using various anti-XAF1 antibodies: (A) Abcam (ab17204); (B) Abcam (ab81353); (C) Aviva System Biology (OAAB14914); (D) Boster (A03432); (E) GeneTex (GTX51339); (F) Invitrogene (PA1-41099); (G) Novus Biologicals (NB100-56355).

    Techniques: Infection, Expressing